Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2021-11-10 Management Reports
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
3Q Operational update
Management Reports Classification · 1% confidence The document is titled "3Q 2021 – operational update 10 November 2021" and contains detailed sections on operational progress, key financial figures for the period ending September 30, 2021 (3Q 2021), financial review, and outlook. It includes unaudited financial statements (tables showing YTD 2021 vs YTD 2020) and discusses strategic developments, acquisitions, and capital increases specific to the third quarter. This structure—a comprehensive review of a specific fiscal period (quarterly) including detailed financials and management discussion—is characteristic of an Interim/Quarterly Report (IR). It is too detailed to be just an Earnings Release (ER) and covers more than just management commentary (MDA) or a general regulatory filing (RNS).
2021-11-10 English
3Q Operational update
Report Publication Announcement Classification · 1% confidence The document is extremely short (571 characters) and explicitly states, "Please find attached Lifecare AS’ operational update for 3Q 2021." It functions as a brief announcement pointing to an attached or linked report (the 3Q Operational update). This perfectly matches the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or publication of company reports, rather than the report itself. The content is not a full Earnings Release (ER) or Interim Report (IR), but a notice about them.
2021-11-10 English
Lifecare – Share capital increase registered
Capital/Financing Update Classification · 1% confidence The document explicitly announces a 'Share capital increase registered' following a private placement. It details the resulting new registered share capital and the total number of shares. This directly relates to changes in the company's capital structure, matching the definition for 'Capital/Financing Update' (CAP). Although it involves shares, it is a registration/completion notice rather than a general announcement of a buyback (POS) or a general share issue (SHA), making CAP the most precise fit for a financing event completion.
2021-11-09 English
Presentation of Forget Diabetes project
Investor Presentation Classification · 1% confidence The document appears to be a presentation or a report detailing a research project titled 'Forget Diabetes: A Novel Automated Insulin Delivery System.' It mentions funding from the European Union's Horizon 2020 programme and outlines various development components (soft containers, pump, sensing system, algorithm). This structure strongly suggests an Investor Presentation (IP) or a detailed project update/factsheet, rather than a formal regulatory filing like a 10-K, ER, or IR. Given the detailed technical and project-based content, Investor Presentation (IP) is the most appropriate classification, as these often serve to update stakeholders on R&D progress.
2021-11-08 English
Presentation of Forget Diabetes project
Investor Presentation Classification · 1% confidence The document is a short announcement (1128 characters) dated November 8, 2021, stating that a presentation held on November 6, 2021, regarding the 'Forget Diabetes project' is enclosed. It describes the content of the presentation (an EU-funded project for an artificial pancreas system) and provides company background. Because the document itself is an announcement that encloses or refers to a presentation material, and it does not fit the specific criteria for an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), it aligns best with the Investor Presentation (IP) category, as it is material presented to stakeholders about a specific project/technology. However, given the structure—a brief stock exchange announcement stating the presentation is 'enclosed'—it could also be interpreted as a general Regulatory Filing (RNS) or a Report Publication Announcement (RPA). Since the core content being shared is a detailed presentation about strategy/technology, Investor Presentation (IP) is the most specific fit for the *enclosed material*, but the document *itself* is an announcement of that material. Given the context of sharing specific project presentation materials, IP is chosen over the general RPA/RNS.
2021-11-08 English
Upcoming events: Lifecare will host webcast operational update for third quarter and Lifecare CSO to present at Diabetes Tech Meeting
Report Publication Announcement Classification · 1% confidence The document announces two upcoming events: a webcast operational update for the third quarter and a presentation by the CSO at the Diabetes Tech Meeting. It details the dates, times, and topics for these events. Since the document is an announcement about future events and presentations, and not the transcript of the call (CT) or the full quarterly report (IR), it best fits the category for general regulatory announcements or investor-related news that doesn't fit a more specific category like DIV or DIRS. Given the content focuses on operational updates and conference presentations, it is a general announcement. Since there is no specific category for 'Upcoming Events Announcement', and it is not a formal report release announcement (RPA), the most appropriate fallback is Regulatory Filings (RNS), as it is a stock exchange announcement.
2021-10-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.